ALLMedicine™ Cholangitis Center
Research & Reviews 3,693 results
https://doi.org/10.1016/j.clinre.2023.102114
Clinics and Research in Hepatology and Gastroenterology; Malkani KV, Jesudian AB et. al.
Mar 27th, 2023 - Primary Biliary Cholangitis (PBC) is an autoimmune liver disease that is sometimes associated with CREST (calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia) syndrome. If left untreated, PBC eventually prog...
https://doi.org/10.1016/j.ajo.2023.03.009
American Journal of Ophthalmology; Kim E, Byon I et. al.
Mar 25th, 2023 - We investigated the rate of ophthalmologic examinations to detect endogenous endophthalmitis in patients with pyogenic liver abscesses (PLAs) and the incidence and risk factors of endophthalmitis from a PLA caused by Klebsiella pneumoniae (PLA-K)....
https://doi.org/10.1093/ecco-jcc/jjad051
Journal of Crohn's & Colitis; Fadel MG, Geropoulos G et. al.
Mar 25th, 2023 - Following ileal pouch-anal anastomosis (IPAA) for ulcerative colitis (UC), up to 16% of patients develop Crohn's disease of the pouch (CDP) which is a major cause of pouch failure. This systematic review and meta-analysis aimed to identify preoper...
https://clinicaltrials.gov/ct2/show/NCT04685200
Mar 23rd, 2023 - Study Description: We hypothesize that primary sclerosing cholangitis (PSC) develops as a consequence of a genetically driven aberrant immune response to commensal or pathogenic bacteria, and that unique genetic-immunemicrobial associations may un...
https://clinicaltrials.gov/ct2/show/NCT05014672
Mar 21st, 2023 - The primary objective of this study is to evaluate the effect of setanaxib on biochemical response at Week 52 in participants with primary biliary cholangitis (PBC) and with elevated liver stiffness and intolerance or inadequate response to ursode...
Guidelines 23 results
https://doi.org/10.1016/j.jhep.2022.05.011
Journal of Hepatology; ,
Jun 24th, 2022 - Management of primary or secondary sclerosing cholangitis is challenging. These Clinical Practice Guidelines have been developed to provide practical guidance on debated topics including diagnostic methods, prognostic assessment, early detection o...
https://doi.org/10.1016/j.clinre.2021.101770
Clinics and Research in Hepatology and Gastroenterology; Corpechot C, Heurgue A et. al.
Aug 1st, 2021 - Primary biliary cholangitis (PBC) is a chronic inflammatory disease of the intra-hepatic bile ducts [1]. It is characterised biologically by chronic cholestasis associated with the presence of specific autoantibodies, and histologically by lesions...
https://doi.org/10.1016/j.clinre.2021.101775
Clinics and Research in Hepatology and Gastroenterology; Chazouillères O, Potier P et. al.
Aug 1st, 2021 - Primary sclerosing cholangitis (PSC) is a rare and chronic cholestatic liver disease of unknown cause commonly associated with inflammatory bowel disease (IBD) and characterized by progressive obliterative fibro-inflammation of the biliary tree. A...
https://doi.org/10.1016/j.gie.2020.12.032
Gastrointestinal Endoscopy; Buxbaum JL, Buitrago C et. al.
May 24th, 2021 - Cholangitis is a GI emergency requiring prompt recognition and treatment. The purpose of this document from the American Society for Gastrointestinal Endoscopy's (ASGE) Standards of Practice Committee is to provide an evidence-based approach for m...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665406
Journal of Crohn's & Colitis; Ng SC, Mak JWY et. al.
Oct 22nd, 2020 - Endoscopy is an essential component in the management of inflammatory bowel disease [IBD]. There is a risk of SARS-CoV-2 transmission during endoscopic procedures. The International Organization for the study of IBD [IOIBD] has developed 11 positi...
Drugs 11 results see all →
Clinicaltrials.gov 339 results
https://clinicaltrials.gov/ct2/show/NCT04685200
Mar 23rd, 2023 - Study Description: We hypothesize that primary sclerosing cholangitis (PSC) develops as a consequence of a genetically driven aberrant immune response to commensal or pathogenic bacteria, and that unique genetic-immunemicrobial associations may un...
https://clinicaltrials.gov/ct2/show/NCT05014672
Mar 21st, 2023 - The primary objective of this study is to evaluate the effect of setanaxib on biochemical response at Week 52 in participants with primary biliary cholangitis (PBC) and with elevated liver stiffness and intolerance or inadequate response to ursode...
https://clinicaltrials.gov/ct2/show/NCT01174121
Mar 17th, 2023 - Background: Metastatic digestive tract cancers, in particular esophageal, gastric, pancreatic and hepatobiliary carcinomas, are associated with poor survival beyond five years and poor response to existing therapies. Data from the National Cancer ...
https://clinicaltrials.gov/ct2/show/NCT04480840
Mar 15th, 2023 - Three-part study: Part 1 - 12-week treatment period evaluating 40 mg of PLN-74809 or matching placebo [Complete] Part 2 - 12-week treatment period evaluating two dose groups, 80 mg and 160 mg of PLN-74809 or matching placebo Part 3 - minimum 24-we...
https://clinicaltrials.gov/ct2/show/NCT03301506
Mar 10th, 2023 - Primary: To evaluate the long-term safety and tolerability of seladelpar Secondary: To evaluate the long-term efficacy of seladelpar To evaluate the effect of seladelpar on patient-reported outcomes (pruritus)
News 334 results
https://www.medpagetoday.com/gastroenterology/generalgastroenterology/102764
Jan 23rd, 2023 - Use of duodenoscopes with disposable elevator caps during endoscopic retrograde cholangiopancreatography (ERCP) led to lower rates of contamination following high-level disinfection compared with standard scope designs, and did not affect the tech...
https://www.mdedge.com/gihepnews/article/260476/pancreas-and-biliary-tract/genomics-data-reveal-promising-psc-therapeutic
Tara Haelle, MDedge News
Jan 4th, 2023 - An investigation of genomics data related to primary sclerosing cholangitis (PSC) in published medical literature revealed several genes likely involved in the pathogenesis of this autoimmune diseases, according to a study published in Gastro Hep.
https://www.mdedge.com/dermatology/article/259180/wounds/hyaluronidase-skin-necrosis-induced-amiodarone
Hannah Y. Wang, BS, Joanne S. Jacob, MD et. al.
Nov 3rd, 2022 - To the Editor: Amiodarone is an oral or intravenous (IV) drug commonly used to treat supraventricular and ventricular arrhythmia as well as atrial fibrillation. 1 Adverse drug reactions associated with the use of amiodarone include pulmonary, gastr.
https://www.onclive.com/view/177lu-fap-2286-displays-preliminary-antitumor-activity-in-advanced-or-metastatic-solid-tumors
Oct 18th, 2022 - The targeted radiotherapy candidate lutetium-177-FAP-2286 (177Lu-FAP-2286) produced preliminary evidence of antitumor activity with a manageable safety profile in patients with advanced or metastatic solid tumors, according to data from the phase ...
https://www.onclive.com/view/treatment-options-for-early-stage-biliary-tract-cancers
Oct 13th, 2022 - Transcript: Milind Javle, MD: Flavio, you raise important issues. I also wonder about the role of surgery in some of these patients who have MSI [microsatellite instability]–high, but we should move on. As I expected, this panel has a lot to say ...